Paige focuses on delivering AI-based diagnostic software solutions. Credit: Paige AI.

The University of Louisville (UofL) Health in the US state of Kentucky has deployed a complete suite of Paige artificial intelligence (AI)-enabled digital pathology software in a bid to enhance cancer diagnosis services.

The move makes UofL Health one of the first health systems to adopt the US Food and Drug Administration (FDA)-approved Paige Prostate solution, which can be used for detecting cancer in prostate biopsies.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

AI-based Paige Prostate has also received CE marking for use in laboratories and hospitals located in the European Economic Area.

As part of the collaboration, UofL Health will also use Paige’s digital pathology image viewer and case management tool, called FullFocus, as well as the breast cancer detection software known as Paige Breast.

Additionally, the health system will use Paige’s Software Development Kit. This offering enables the deployment of customised laboratory-developed tests for digital pathology as well as the use of AI algorithms to enhance operational efficiencies and image analysis.

Paige chief commercial officer Andy Moye said: “Completing our deployment at UofL Health is an exciting milestone for Paige as we help hospital systems adopt digital, AI-based technologies to make their existing workflows more accurate and efficient.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are proud to offer a robust portfolio of AI-enabled digital pathology technologies backed by the FDA.

“We are also excited to see how the UofL is utilising the Paige Software Development Kit to achieve near-term clinical impact, and we hope this will be the first of many research applications adopting our open technology to improve patient care.”

Founded in 2017, Paige focuses on delivering AI-based diagnostic software solutions.

Earlier this year, Quest Diagnostics partnered with Paige to develop software products that would facilitate pathologic diagnoses of cancer as well as various other diseases.